High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study

A prospective randomized phase III study was performed to evaluate whether intensified cytarabine would induce a higher response rate and longer event-free interval as compared to low-dose cytarabine in chronic myeloid leukemia (CML). One hundred and eighteen patients with CML in early chronic phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Deenik, W., van der Holt, B., Verhoef, G. E. G., Schattenberg, A. V. M. B., Verdonck, L. F., Daenen, S. M. G. J., Zachée, P., Westveer, P. H. M., Smit, W. M., Wittebol, S., Schouten, H. C., Löwenberg, B., Ossenkoppele, G. J., Cornelissen, J. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2006
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101742/
https://www.ncbi.nlm.nih.gov/pubmed/17031690
http://dx.doi.org/10.1007/s00277-006-0186-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101742/
https://www.ncbi.nlm.nih.gov/pubmed/17031690
http://dx.doi.org/10.1007/s00277-006-0186-1

Ejemplares similares